Clinical Trial Update: A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating paclitaxel and carboplatin with bexarotene in advanced non-small-cell lung carcinoma was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bexarotene (Bexarotene)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Carcinoma, Non-small-cell Lung | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-03-06